life
Navigation Links
life at medicine technology
Lab Automation Networks Proliferating
Although it may still seem radically innovative in the context of many clinical laboratories, automated production in the manufacturing sector had been the norm for many years. In automobile assembly, for example, automated lines fabricate sub-assemblies and entire vehicles with only occasional human oversight. The result has been vastly improved products, far fewer defects, and significant p...FRAMINGHAM, Mass.--(BUSINESS WIRE)--Jul 5, 2007 - GTCBiotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today thatGeoffrey Cox, Ph.D., GTC's Chairman and CEO, is scheduled topresent on Wednesday, July 11, 2007 at 9:00 a.m. during the C.E.Unterberg, Towbin Emerging Growth Life Opportunities Conference.The conference is being held at the Mandarin Oriental Hotel, NewYork, New York from July...
HYDERABAD, India, July 5th, 2007 – Several datapresentations from Suven’s portfolio of investigationalneuroscience compounds will be presented at International Brain Research Organisation (IBRO) 2007 WorldCongress of Neuroscience to be held at Melbourne, Australia duringJuly 12-17, 2007. Scientists from Suven Discovery Research will be presenting newdata for 4 p...
Provides Update to Timeline for Second Pivotal Phase 3 Trial CL-05 CHICAGO, July 02, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. , today announced the confirmation ofsupplemental efficacy data from Trial CL-06, the first of twopivotal Phase 3 clinical trials designed to assess the safety andeffectiveness of cethromycin, a novel once-a-day antibiotic, forthe treatme...
CHICAGO, June 29, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. , today announced that it will host aconference call and live webcast at 10:00 am (EDT) on Monday, July2, 2007 to discuss data from Trial CL-06, the first of two pivotalPhase 3 clinical trials designed to assess the safety andeffectiveness of cethromycin, a novel once-a-day antibiotic, forthe treatment...
HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
BOSTON--(BUSINESS WIRE)--Jun 25, 2007 - HepaLife Technologies, Inc.(OTCBB: HPLF) (FWB: HL1) (WKN: 500625) today announced that newdata presented at an international influenza research conferencedemonstrates that HepaLife's patented PBS-1 cell line outperformscurrent cell technologies at replicating human influenza virusinside its cells. The most important step towards the production ofa cel...Independent Study Indicates 20-50% Improvement in Post-PreservationFunctional Recovery of Peripheral Blood Stem Cells for CancerTherapy BOTHELL, Wash., June 25, 2007 /PRNewswire-FirstCall/ -- BioLifeSolutions Inc. , a leading developer and marketer of proprietaryhypothermic storage and cryopreservation media products for cells,tissues, and organs, today presented data from an independent...
MIAMI--(BUSINESS WIRE)--Jun 21, 2007 - Answerthink, Inc. (NASDAQ:ANSR) announced today that it has formed a strategic alliance withLORENZ Life Sciences Group for the distribution of LORENZ solutionsin North America. Answerthink and LORENZ Life Sciences Group willserve midsize companies by integrating best practice submissionsmanagement solutions into Answerthink's Life Science solutionsbase...
Heads into US Phase II Clinical Trials for Organ Transplantation HORSHOLM, Denmark, May 31, 2007 /PRNewswire-FirstCall/ --LifeCycle Pharma announces positive Phase I clinical results forits transplantation product candidate, LCP-Tacro - Heads into USPhase II clinical trials for organ transplantation. Today LifeCycle Pharma A/S (OMX:LCP) announces positive resultsfrom its Phase I cli...
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
BOSTON--(BUSINESS WIRE)--May 29, 2007 - HepaLife Technologies, Inc.(OTCBB:HPLF) (FWB:HL1) (WKN:500625) is pleased to announce ascientific presentation of its cell based PBS-1 technology forpotential influenza vaccine production at the "Options for theControl of Influenza VI Conference," to be held June 17-23, 2007,in Toronto, Canada. Entitled "High titer growth of human and avian influenz...WASHINGTON, May 22, 2007 /PRNewswire/ -- Results from analyseslooking at factors contributing to successful treatment ofulcerative colitis (UC), were presented at Digestive Disease Week(DDW) this week. Both of these studies were funded by Procter &Gamble (P&G) Pharmaceuticals, Inc. Findings from one studyoffer new information on improvement of quality of life for UCpatients t...
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
UC's Overall Psychological Toll Is Greater Than for Asthma,Rheumatoid Arthritis and Migraines WAYNE, Pa., May 17, 2007 /PRNewswire/ -- Nearly three out offour ulcerative colitis (UC) sufferers (73 percent) responding to anew nationwide survey say not feeling well has become a normal partof life. Furthermore, they describe UC as disruptive when it comesto their relationship with a spouse (...Company Announces Extension of Phase I/IIa Trial to 9 mg DosageLevel HOPKINTON, Mass., April 16, 2007 /PRNewswire-FirstCall/ --Boston Life Sciences announced today that clinical data on its leadnerve repair therapy, Cethrin(R), were presented in the Neurotraumaand Critical Care Scientific Session at the 75th Annual Meeting ofthe American Association of Neurological Surgeons (AANS) inWash...
Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
MELBOURNE, Australia, March 23, 2007 /PRNewswire/ -- Scientistsat WEHI have made a discovery with potentially profoundimplications for the care of patients, especially those undergoingcancer chemotherapy. The research team led by Drs Benjamin Kile and David Huang hasdiscovered that platelet life span is controlled by two keymolecules. The discovery raises the prospect of developing...Other TagslistedviaviaviaviaviaviaSantadaughterseducatedOther Contentsflavindiffusiondiffusiondiffusiondiffusiondiffusionlawlawlawlawlawlawlawsolutionsolutionsolutionsolutionsolutionsolutionsolutionsolutionsolutionlandscapelandscapelandscapelandscapelandscapelandscapefitnessfitnessfitnessfitnessfitnessfitnessfermentationfermentationfermentationfermentationfermentationfermentationflagellumflagellum
unearthrememberlistedantelopepoisedintermediaryviaaccessoryBarbaraSantadaughterseducatedunderfundedrepairing
(Date:5/16/2008)..., Researchers at the National Institute of Sta...technique to sort batches of carbon nanotubes by l... applications for carbon nanotubes depend on the l...the most important features of the new technique, ...alable to produce industrial quantities of high-qu...
(Date:5/16/2008)...St. Louis, May 16, 2008 Changing the sugars attac...ncreased fertility levels in mice nearly 50 percen...l of Medicine in St. Louis has found. The change a...ling part of an intricate regulatory system that m... "To adjust for the right amount of key reproducti...
(Date:5/16/2008)...BIRMINGHAM, Ala. A new study reveals the genetic ...e version responsible for sexual transmission, in ...ortant clues in the ongoing search for an effectiv...sity of Alabama at Birmingham (UAB). The UAB team ...ew lead to sexual transmission. , Earlier studie...
(Date:5/16/2008)...Parental concerns in maintaining germ-free homes f...emand and the rapid adoption of anti-bacterial soa... of those antiseptic soaps now have come under scr...l and human health concerns. , Two closely rel...re at the center of the debacle. Whereas triclosan...
Breaking Biology News(10 mins):Spin control: New technique sorts nanotubes by length 2Disabling mouse enzyme increases fertility 2HIV infection stems from few viruses 2New study links fate of personal care products to environmental pollution and human health concerns 2New study links fate of personal care products to environmental pollution and human health concerns 3Testosterone Spray Improves Sexual Satisfaction in Women 16771 1Testosterone Spray Improves Sexual Satisfaction in Women 16771 2The HealthQuake Summit to Explore Healthcare Landscape of the Future 16766 1Cogdell Spencer Inc Announces First Quarter Earnings Release and Conference Call Notice 16761 1Cogdell Spencer Inc Announces First Quarter Earnings Release and Conference Call Notice 16761 2Micromet Demonstrates That the Antibodies in Commercial Products Herceptin Erbitux Vectibix and Xolair Can Be Converted Into Highly Potent T Cell 1775 1Micromet Demonstrates That the Antibodies in Commercial Products Herceptin Erbitux Vectibix and Xolair Can Be Converted Into Highly Potent T Cell 1775 2Micromet Demonstrates That the Antibodies in Commercial Products Herceptin Erbitux Vectibix and Xolair Can Be Converted Into Highly Potent T Cell 1775 3Micromet Demonstrates That the Antibodies in Commercial Products Herceptin Erbitux Vectibix and Xolair Can Be Converted Into Highly Potent T Cell 1775 4Micromet Demonstrates That the Antibodies in Commercial Products Herceptin Erbitux Vectibix and Xolair Can Be Converted Into Highly Potent T Cell 1775 5(Date:5/17/2008)...ampaign on Behalf of CSL Behring, maker of Zema...ntation Therapy, K...a Biggs, a fashion,designer and actress who appear... an education campaign on behalf of CSL Behring, a...ntitrypsin (AAT) deficiency,after her own diagnosi...
(Date:5/16/2008)... Law Offices of Howard G. Smith,announces a June 9... the,securities class action lawsuit filed on beha...red the common stock of Inverness Medical,Innovati...Amex: IMA ) in the,Company,s secondary public off...riod"). The shareholder lawsuit is pending in the ...
(Date:5/16/2008)...critics want agency to act, not wait years , ...o-consumer drug ads on television should include a... to report adverse side effects, U.S. health exper...anel that advises the U.S. Food and Drug Administr...the FDA for print ads. At Friday,s meeting, the pa...
(Date:5/16/2008)..., WASHINGTON, May 16 /PRNewswire-USNewswire/ -- M...nicians in the Greater Portland, Oregon and,Vancou...r contract as,Teamsters., "The Teamsters are plea... contract that gives them job protection and a sec...sident Jim Hoffa., The workers, both full-time an...
Breaking Medicine News(10 mins):Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 4Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 5Health News:Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc. 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3[0] Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease[0] Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.[0] FDA Panel Considers Toll-Free Number for TV Drug Ads[0] Paramedics, EMTs in Oregon, Washington State Ratify First-Ever Teamsters Contract
| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |